Thank you all for making Life Science Investment Day Scandinavia 2011 a success!
With almost 300 delegates and more than 220 one-on-one meetings Life Science Investment Day Scandinavia 2011 sets a new standard for Life Science B2B events in Scandinavia. SwedenBIO would like to thank all participants, companies, investors and sponsors for making this year's event the most successful yet.
Official Program Life Science Investment Day Scandinavia 2011
Click here to download the Official Program for Life Science Investment Day Scandinavia 2011.
For information about the 30 presenting companies, click here.
The Presenting companies:
AS-Faktor, Affibody, Atlas Antibodies, Axongen, BeneChill, BioInvent, BioResonator, Bioservo Technoloiges, BoneSupport, Doxa, Exthera, Gyros, Halo Genomics, Immunicum, Isconova, Kancera, Medfield Diagnostics, Metakalinin, Mivac Development, Nanologica, Oncos, Photocure, QuickCool, RxEye, SciBase, Thrombologic, Vaccibody, Viscogel, Wilex and XSpray.
Among the International and Scandinavian investors and strategic partners:
Aravis, Boehringer Ingelheim Venture Fund, DnB NOR, Forbion Capital Partners, Gilde, GSK CEEDD, HealthCap, Industrifonden, Lundbeckfond Ventures, Merck Serono Ventures, MVM Life Science Partners, Novartis Venture Funds, Novo Seeds, SEB Venture Capital, SLS Invest and TVM Capital.
Life Science Investment Day Scandinavia 2011 will have presentations from 30 companies in 3 parallel sessions with focus on Drug Discovery & Therapeutics, Medtech and Enabling Technologies & Diagnostics, respectively. In addition, the Main Stage will have an International Session with international partners from USA, China and India.
Amgen Keynote Lecture:
- Jeremy Haigh, Vice-President International, Chief Operating Officer, Research & Development, Amgen UK
Amgen Partnering Seminar:
- Iain Dukes, Vice President, External Research and Development, Amgen USA
For additional information please contact:
Dr. Olof Nord
E-mail: olof.nord@swedenbio.com
Tel: +46-73 330 50 10
Picture from Life Science Investment Day Scandinavia 2011.
Panel Discussion: Life Science Forecaster
From the left: Eugen Steiner HealthCap, Iain Dukes Amgen USA, Roel Bulthius Merck Serono Ventures, Christina Takke Forbion Capital Partners and Erik Lund MSD
 |
| Foto: Tobias Fischer |